Literature DB >> 30698408

Genetic Analyses of Alzheimer's Disease in China: Achievements and Perspectives.

Deng-Feng Zhang1, Min Xu1,2, Rui Bi1, Yong-Gang Yao1,2,3,4.   

Abstract

Since 2010, the Chinese have become one of the most aged populations in the world, leading to a severe burden of neurodegenerative disorders. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease and has a high genetic heritability. In the past two decades, numerous genetic analyses, from linkage analyses and candidate gene studies to genome-wide association studies (GWASs) and next-generation sequencing studies, have identified dozens of AD susceptibility or causal genes. These studies have provided a comprehensive genetic view and contributed to the understanding of the pathological and molecular mechanisms of the disease. However, most of the recognized AD genetic risk factors have been reported in studies based on European populations or populations of European ancestry, and data about the genetics of AD from other populations has been very limited. As China has the largest AD population in the world and because of the remarkable genetic differences between the East and the West, deciphering the genetic basis and molecular mechanism in Chinese patients with AD may add key points to the full characterization of AD. In this review, we present an overview of the current state of AD genetic research in China, with an emphasis on genome-level studies. We also describe the challenges and opportunities for future advances, especially for in-depth collaborations, brain bank construction, and primate animal modeling. There is an urgent need to promote public awareness and increase our collaborations and data sharing.

Entities:  

Keywords:  Alzheimer’s disease; Chinese; genome-wide association study; linkage analysis; next generation sequencing; risk gene

Mesh:

Year:  2019        PMID: 30698408     DOI: 10.1021/acschemneuro.8b00435

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  5 in total

1.  Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1H)-Quinolinone-Dithiocarbamate Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease.

Authors:  Jie Guo; Airen Xu; Maojun Cheng; Yang Wan; Rikang Wang; Yuanying Fang; Yi Jin; Sai-Sai Xie; Jing Liu
Journal:  Drug Des Devel Ther       Date:  2022-05-18       Impact factor: 4.319

Review 2.  Physiological and pathological insights into exosomes in the brain.

Authors:  Xiao-Hui Li; Juan Zhang; Ding-Feng Li; Wei Wu; Zhong-Wen Xie; Qiang Liu
Journal:  Zool Res       Date:  2020-07-18

3.  A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline.

Authors:  Rongcan Luo; Yu Fan; Jing Yang; Maosen Ye; Deng-Feng Zhang; Kun Guo; Xiao Li; Rui Bi; Min Xu; Lu-Xiu Yang; Yu Li; Xiaoqian Ran; Hong-Yan Jiang; Chen Zhang; Liwen Tan; Nengyin Sheng; Yong-Gang Yao
Journal:  Signal Transduct Target Ther       Date:  2021-08-31

4.  CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ 1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway.

Authors:  Chuan Guo; Qinxuan Li; Jiujia Xiao; Xuhui Zhou; Meichen Tian; Lei Xie; Xun Xia
Journal:  Comput Math Methods Med       Date:  2022-09-08       Impact factor: 2.809

5.  Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer's Disease in the Southern Han Chinese Population.

Authors:  Xuewen Xiao; Bin Jiao; Xinxin Liao; Weiwei Zhang; Zhenhua Yuan; Lina Guo; Xin Wang; Lu Zhou; Xixi Liu; Xinxiang Yan; Beisha Tang; Lu Shen
Journal:  Front Aging Neurosci       Date:  2020-11-06       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.